This site might not work as expected.
You're using an old browser that isn't supported by this site. Please upgrade or download one of these free and excellent browsers: https://browser-update.org/update.html

Wolters Kluwer Completes Sale of Its Pharma-Related Marketing & Publishing Services Business to Springer Science+Business Media

Division to Focus on Core Health Markets, Point-of-Care Solutions

​Wolters Kluwer, a market-leading global information services company focused on professionals, today announced that it has completed the sale of its pharma-related Marketing & Publishing Services business to Springer Science+Business Media. The sale is part of Wolters Kluwer’s strategy to focus on core health markets through its Wolters Kluwer Health & Pharma Solutions division.

“The sale of our pharma-related business will allow us to focus future investments in our core healthcare business in key growth areas such as point of care,” said Nancy McKinstry,  CEO and Chairman of the Executive Board of Wolters Kluwer. “We are committed to continued investments in innovative solutions that help clinicians around the globe access critical information to improve healthcare.”

The agreement encompasses the Marketing & Publishing Services business unit, part of the Wolters Kluwer Health & Pharma Solutions division. Marketing & Publishing Services is a leading global provider of strategic marketing, publishing, and business intelligence products and services to the pharmaceutical industry as well as to medical libraries and academic and research institutions. The sale represents approximately 35% of the company’s pharma-related assets in terms of revenue, with Adis and  inScience Communications as the leading brands, and encompasses approximately 450 employees globally.

The intention to divest the Pharma Solutions business was announced in July 2011. The proceeds from this divestment are expected to be used for general corporate purposes including the reduction of debt levels in line with the company’s stated objectives and investments in the business. Terms of the deal were not disclosed.

For more information on Wolters Kluwer Health, visit  www.wolterskluwerhealth.com. For more information on Pharma Solutions, visit  www.wolterskluwerpharma.com.

About Wolters Kluwer
Wolters Kluwer is a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer’s leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer had 2010 annual revenues of €3.6 billion, employs approximately 19,000 people worldwide, and maintains operations across Europe, North America, Asia Pacific, and Latin America, serving customers globally. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.